-->

Tag: Endometrial cancer immunotherapy

Home / Endometrial cancer immunotherapy

Categories

The FDA has broadened the indication for dostarlimab-gxly to include the treatment of endometrial cancer in combination with chemotherapy

August 2024: The Food and Drug Administration has granted approval for dostarlimab-gxly (Jemperli, GSK) in combination with carboplatin and paclitaxel, followed by single-agent dostarlimab-gxly, for t...
endometrial-cancer-immunotherapy

uterine cancer immunotherapy


endometrial-cancer-immunotherapy

Scan the code